Free Trial

Novavax (NVAX) Earnings Date, Estimates & Call Transcripts

Novavax logo
$5.99 -0.67 (-10.06%)
As of 05/9/2025 03:58 PM Eastern

Novavax Earnings Summary

Novavax announced Q1 2025 earnings on May 9, 2025, reporting an EPS of $2.93, which topped the consensus estimate of $0.19 by $2.74. Quarterly revenue rose 610.3% year-over-year to $666.66 million, above analyst estimates of $204.08 million. With a trailing EPS of -$1.33, Novavax's earnings are expected to grow next year, from ($1.46) to $0.08 per share.

Latest Q1
Earnings Date
May. 9Estimated
Consensus EPS
(May. 9)
$0.19
Actual EPS
(May. 9)
$2.93 Beat By $2.74
Actual Revenue
(May. 9)
$666.66M

Q1 2025 Earnings Resources

Get Novavax Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Novavax and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

NVAX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NVAX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Novavax Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue Guidance
Q1 20252-$0.46-$0.43-$0.45
Q2 20252$0.38$0.64$0.51
Q3 20252-$0.47-$0.39-$0.43
Q4 20252-$0.48-$0.16-$0.32
FY 2025 8 -$1.03 -$0.34 -$0.69
Q1 20261-$0.13-$0.13-$0.13
Q2 20261$0.15$0.15$0.15
Q3 20261-$0.10-$0.10-$0.10
Q4 20261$0.40$0.40$0.40

Novavax Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/9/2025Q1 2025$0.19$2.93+$2.74$2.93$204.08M$666.66M
2/27/2025Q4 2024-$0.75-$0.51+$0.24-$0.51$85.48M$88.31M
11/12/2024Q3 2024-$0.83-$0.76+$0.07-$0.76$65.80M$84.51M
8/8/2024Q2 2024$1.82$0.99 -$0.83$0.99$458.57M$415.50M
5/10/2024Q1 2024-$1.04-$1.05 -$0.01-$1.05$71.32M$93.90M
2/28/2024Q4 2023-$0.49-$1.44 -$0.95-$1.44$310.96M$291.34M
11/9/2023Q3 2023-$1.82-$1.26+$0.56-$1.26$171.04M$187.00M
8/8/2023Q2 2023-$1.24$0.58+$1.82$0.58$264.16M$424.40M

Novavax Earnings - Frequently Asked Questions

Novavax (NASDAQ:NVAX) last announced its quarterly earning data on Friday, May 9, 2025. Learn more on NVAX's earnings history.

Novavax issued an update on its FY 2025 earnings guidance on Thursday, May, 8th. The company issued revenue guidance of $975.0 million-$1.0 billion.

In the previous quarter, Novavax (NASDAQ:NVAX) reported $2.93 earnings per share (EPS) to beat the analysts' consensus estimate of $0.19 by $2.74. Learn more on analysts' earnings estimate vs. NVAX's actual earnings.

The conference call for Novavax's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Novavax's latest earnings report can be read online.
Read Transcript

Novavax's earnings report can be found in their filing with the SEC.
View SEC filing

Novavax (NASDAQ:NVAX) has a recorded annual revenue of $682.16 million.

Novavax (NASDAQ:NVAX) has a recorded net income of -$545.06 million. NVAX has generated -$1.33 earnings per share over the last four quarters.

Novavax (NASDAQ:NVAX) has a . The price/earnings-to-growth ratio is 2.85.

Novavax's earnings are expected to grow from ($1.46) per share to $0.08 per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:NVAX) was last updated on 5/11/2025 by MarketBeat.com Staff
From Our Partners